Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Debra Stewart

Debra Stewart

Advocate and Consultant for Health and Wellness Professor, Ashford University USA

Sang-Wha Lee

Sang-Wha Lee

Gachon University South Korea

Seong Soo A. An

Seong Soo A. An

Gachon Gil Hospital, South Korea

Robin Lombardo

Robin Lombardo

Regional Director, Music and Memory USA

Debi Harmon Ference

Debi Harmon Ference

Member of Epilepsy Board in Maumee USA

Van Giau Vo

Van Giau Vo

Assistance Professor, Gachon University South Korea

Alzheimers Summit 2018

About Conference


Details of Alzheimer's Summit 2018 in USA.

Conference series LLC Ltd is organizing Alzheimer’s Summit in 2018 at Boston, USA. We organise meetings in the distinctive sectors of Alzheimer’s disease, Vascular Dementia, Aging and Gerontology, Geriatrics Care, Memory Disorders, Neuro-immunology, Movement Disorders, Neuroinfectious Diseases, Neuro-Oncology, Neuro-Ophthalmology and Dementia Care Practice and Research.

 

Conference Name:

Place:

Date:

Alzheimer summit 2018

Boston, Massachusetts, USA.

Aug 31 – Sept 01, 2018.

 
It is a great pleasure to welcome you to Boston, Massachusetts, USA on behalf of Organizing Committee for the 14th World summit on Alzheimer’s disease, Dementia Care Research and Awareness scheduled on August 31–September 01 2018. , Alzheimer’s summit 2018 conference creates a platform for expert’s interaction simultaneously with networking opportunities and also provides an opportunity to explore the innovative ideas of the other communities, companies and associations. 

Being held in the breath-taking city of Boston, Alzheimer’s summit 2018 will be the ideal meeting point ​for the leading Neurologists, Neuroscientists, Neurosurgeons, Neuroradiologists, Interventional radiologists, Physiatrists, Emergency medicine specialistsInternational speakers, Scientists, Researchers, University Professors, Students, College Faculty members, Primary care Physicians, Hospitalists, Nurses and Nurse practitioners, Rehabilitation specialists, Physical, Occupational and speech Therapists, Pharmacists, Business Entrepreneurs, Healthcare professionals and investigators to meet, network with different medical and scientific interactions. As a special designed cluster forum of Keynote talks, Plenary sessions, Workshops and Symposia along with Oral and Poster presentations, panel discussions with round table sessions focusing on interdisciplinary aspects as well as current and future concepts for epidemiology, research, prevention, and treatment of Neurological disorders like StrokesPaediatric stroke, Nursing, Neurocritical care, Alzheimer’s and Dementia and diagnostic methods/devices, biomarkers and on-going Clinical trials..

It is an meticulous program which is scheduled for two days with the theme of “Emerging Concepts, Progressions and Awareness in Alzheimer’s Disease and Dementia. Let us unite to expand the knowledge on Alzheimer’s disease, Dementia Care Research and its Awareness on Aug 31 – September 01 2018, Boston, Massachusetts, USA. Overall, we need to learn from each other, share knowledge and best nearby practices to favourably manage our patients.

The Motto and exigency of Alzheimer’s disease, Dementia Care Research and Awareness:

As you are aware, Neurodegenerative disorders like Alzheimer’s disease and dementia is an emergent condition in USA and European countries like France, Germany and Poland over the last decade. This summit means to provide an in-depth review of the pathophysiology, diagnostic methods, and therapeutic approaches of Alzheimer’s and to raise awareness on it. Internationals and national experts will talk and share the most recent ideas and harmony in the Management of Alzheimer’s and Dementia.

This conference escalates the expertise of all members in their distinctive sectors of Alzheimer’s Disease Causes, Alzheimer’s Disease Pathogenesis and mechanisms, Clinical Trials on Alzheimer’s Disease, Vascular Dementia, Aging and Gerontology, Geriatrics Care Practice and Awareness Neuroscience, Cognitive Neuroscience and Artificial Intelligence, Neurodegeneration and Genetics, Memory Disorders, Neuro-immunology, Movement Disorders, Neuroinfectious Diseases, Neuro-Oncology, Neurology and Neurosurgery, Neurological diagnostic Biomarker, Neuro-Ophthalmology, Nursing Interventions, Care and Outcomes, Dementia Care Practice and Research, Neurology Palliative Care, Neuro stroke, Mood disorders, Neuropharmacology and Neurobiochemistry.

Alzheimer's can be defined as a gradually progressive neurodegenerative disease characterized of memory impairment and subsequent disturbances in personality, mood, reasoning and perception, Beta amyloid plaques and Neurofibrillary tangles of tau protein pathology are prime suspects of neuronal cell death in Alzheimer’s, Patients with high cholesterol levels in the blood, Hypertension, Diabetes,  Smoking and Obesity are the major modifiable risk factors for cardiovascular diseases which would be an risk factors  for both Alzheimer's disease and vascular dementia.

Dementia is a collective word of brain diseases that characterised of mental illness, Personality impairment, Mood disorders, Psychological impairment, Cognitive alteration, Sleep disorder, Muscular functioning and Hallucinations, where amnesia is the prime symptom of it, And it is also crucial to remember the fact that dementia isn't always a natural a part of aging.

Boston City 

Boston is one of the oldest cities in the United States founded in 1630, and the capital city of Massachusetts it is a fine metropolitan city that covers the census-estimated 4.8 million people in 2016 and ranking as the tenth-largest such area in the country. It is occupied by many colleges and universities which makes it an international centre of higher education, Boston is surrounded by the "Greater Boston" region and is contiguously bordered by the cities and towns of Winthrop, Revere, Chelsea, Everett, Somerville, Cambridge, Watertown, Newton, Brookline, Needham, Dedham, Canton, Milton, and Quincy.

Boston education is highly ranked and some of the most renowned and top universities in the world are located near Boston. Three universities with a major presence in the city, Harvard, MIT, and Tufts, are located just outside of Boston in the cities of Cambridge and Somerville, known as the Brainpower Triangle.

About its clime summers are typically warm and humid, while winters are cold and stormy, with occasional periods of heavy snow, spring and fall are usually cool to mild. Fog is fairly common, particularly in spring and early summer. While coming to its economy, Boston is among the top 30 most economically powerful cities in the world. Encompassing $363 billion, the Greater Boston metropolitan area has the sixth-largest economy in the country and 12th-largest in the world.

The city of Boston has got many spots to visit are Freedom tail, boston public garden, museums, parks, sights and landmarks and water sports, And visiting nearby cities (a big bonus in Boston, since New York is right next door). And there is always some sort of festival; after all, there are 250,000 students in this buzzing city. Whenever you visit Boston, it really does have something for everyone and certainly Boston has it all.

Who to attend:

This is a great platform to enhance the knowledge and to socialized with confederates, Professors, scholars, Research scientists, colleagues and peers from various sectors across the world, it reinforce and refresh your thoughts on Neurodegenerative disorders, It gives you an opportunity to present researches, to promote the products, new technologies and services through exhibiting it, Beyond the sessions, enjoy the time you have abroad. Spend some time sightseeing and visiting nearby cities.

link us here

Target Audience:

Neurologists, Physicians, Neuroscientists, Specialists, Researchers, Health care professionals, Professors, Industrial Experts, Neurosurgeons, Psychiatrist, Nutritional Scientists, Lecturers and Students from Academia in the study of Alzheimer and Dementia and Students from Academia in the research of Neurology

Scope and Overview

Alzheimer's is the most widely recognized type of dementia, a general term for memory misfortune and other subjective capacities sufficiently genuine to meddle with everyday life. Alzheimer's illness represents 60 to 80 percent of dementia cases.

Alzheimer's exacerbates after some time. Alzheimer's is a dynamic ailment, where dementia side effects bit by bit exacerbate over various years. In its beginning times, memory misfortune is gentle, yet with late-arrange Alzheimer's, people lose the capacity to bear on a discussion and react to their condition. Alzheimer's is the 6th driving reason for death in the United States. Those with Alzheimer's experience a normal of eight years after their side effects end up noticeably recognizable to others, however survival can run from four to 20 years, contingent upon age and other wellbeing conditions.

Today, there is an overall exertion under approach to discover better approaches to treat the malady, defer its beginning, and keep it from creating.

Scientific Sessions

Scientific Sessions/Tracks

We invite the contributions related to 14th International summit on Alzheimer’s disease, Dementia Care Research and Awareness scheduled on August 31–September 01 2018. This is the best point to meet and assemble professors, Chairs, Dean’s, Assistant & Associate professors, Lecturers, scholars, Delegates and researcher practitioners from all the corners of the world to talk, share, debate and spotlight the most recent clinical approaches and therapeutics in overcoming neurodegenerative disorders and to raise awareness among individuals,

It is a meticulous program which is scheduled for two days with the theme of Emerging Concepts, Progressions and Awareness in Alzheimer’s Disease and Dementia”.

You can submit your work in these broad themes (or) any other topics related to the themes. Abstracts of all the related interest areas are accepted, but are not limited to the following sessions:

Conference Sessions and Highlights

Alzheimer’s Summit 2018 invites the best expertise to share their research experiences from various sectors of evolving fields of Alzheimer’s Disease Causes| Diagnosis and Prevention| Alzheimer’s Disease Pathogenesis and mechanisms | Clinical Trials on Alzheimer’s Disease| Vascular Dementia| Aging and Gerontology| Geriatrics Care Practice and Awareness Neuroscience| Cognitive Neuroscience and Artificial Intelligence| Neurodegeneration and Genetics| Memory Disorders| Neuro-immunology| Movement Disorders| Neuroinfectious Diseases| Neuro-Oncology| Neurology and Neurosurgery| Neurological diagnostic Biomarker| Neuro-Ophthalmology| Nursing Interventions| Care and Outcomes| Dementia Care Practice and Research| Neurology Palliative Care| Neuro stroke| mood disorders| Neuropharmacology and Neurobiochemistry.

Session on  Alzheimer’s Disease Causes, Diagnosis and Prevention

Alzheimer's can be defined as a gradually progressive neurodegenerative disease characterized of memory impairment and subsequent disturbances in personality, mood, reasoning and perception. It caused by a combination of lifestyle, genetic, and environmental factors that gradually impairs the brain.

It can be diagnosed by evaluating subject’s medical history, testing mental and mood status (NINCDS-ADRDA), lab tests and brain scans. An ongoing clinical trial conducted by Dominantly Inherited Alzheimer Network (DIAN), is to test whether antibodies to beta-amyloid can reduce the accumulation of beta-amyloid plaque in the brains with such genetic mutations and thereby reduce, delay or prevent symptoms and it can also be impeded by choosing the diet carefully.

Related Topics:  Down syndrome | Sporadic Alzheimer’s Disease| Familial Alzheimer’s disease (FAD)| Medical and Lifestyle Exposures | Genetic Risk Factors

7th International Conference on Addiction Research & Therapy, Sept 19-20 2018, San Diego, USA; World Summit on Spine and Spinal Disorders, July 27-28, 2018, Atlanta, USA.  World Summit on Alzheimer’s Disease, Dementia Care Research and Awareness, Aug 31-Sept 01, 2018, Boston, USA; International Conference on Brain Disorders and Dementia Care, Sept 21-22, 2018, Philadelphia, USA; International Conference on Sleep Disorders and Medicine, Sept 21-22, 2018, Philadelphia, USA; International Conference on Neuroimmunology and Neurological Disorders, Sept 26-27, 2018, Montreal, Canada ; World Summit on Neurology & Neuroscience, Sept 26-27, 2018, Montreal, Canada ; 5th International Conference on Parkinson’s Disease & Movement Disorders, Oct 19-20, 2018, Baltimore, USA; 7th International Conference on Neurological Disorders &Stroke, September 20-21, 2018, Rome, Italy; 27th International Conference on Neurology and Cognitive Neuroscience, October 18-19, 2018, Warsaw, Poland; 4th International Conference on Central Nervous System Disorders & Therapeutics, November 12-14, 2018, Edinburgh, Scotland.

Session on  Alzheimer’s disease Pathogenesis and mechanisms

Beta amyloid plaques and Neurofibrillary tangles of tau protein Pathology are prime suspects of neuronal cell death in Alzheimer’s it caused by accumulation of abnormally folded A-beta and tau proteins  and Plaques of small peptides 39–43 amino acids to  form Beta-amyloid which comprises amyloid precursor protein (APP) and a transmembrane protein that pierce the neuron's membrane. It later forms a fibrils of amyloid protein clump which get deposited in neurons to form a dense senile plaques, amyloid fibrils disrupts the cell’s calcium ions homeostasis and induces apoptosis of neurons which results in neurodegeneration affecting brain functioning.

Related Topics:  Tau Pathology of Alzheimer's Disease| Pathobiology of ApoE | Pathogenesis of Alzheimer's Disease | Cognitive Impairment and Neuroinflammation in Alzheimer's Disease | Rehabilitation Therapies for Alzheimer’s Disease | Campylobacter Jejuni Pathogenesis | Pathogenesis of Diabetic Nephropathy| Synaptic And Neuritic Alterations | Rapid Progression | Cerebrovascular Pathology | Cerebral Amyloid Angiopathy | Cholinergic Hypothesis | Cellular Signalling and cell transmission | Oxidative damage and Mitochondrial dysfunction | Blood-brain barrier Neurogenesis 

4th International Conference on Central Nervous System Disorders & Therapeutics, November 12-14, 2018, Edinburgh, Scotland. World Summit on Spine and Spinal Disorders, July 27-28, 2018,  Atlanta, USA. World Summit on Alzheimer’s Disease, Dementia Care Research and Awareness, Aug 31-Sept 01, 2018, Boston, USA; 7th International Conference on Addiction Research & Therapy, Sept 19-20 2018, San Diego, USA; International Conference on Brain Disorders and Dementia Care, Sept 21-22, 2018, Philadelphia, USA; International Conference on Sleep Disorders and Medicine, Sept 21-22, 2018, Philadelphia, USA; International Conference on Neuroimmunology and Neurological Disorders, Sept 26-27, 2018, Montreal, Canada ; World Summit on Neurology & Neuroscience, Sept 26-27, 2018, Montreal, Canada ; 5th International Conference on Parkinson’s Disease & Movement Disorders, Oct 19-20, 2018, Baltimore, USA; 7th International Conference on Neurological Disorders & Stroke, September 20-21, 2018, Rome, Italy; 27th International Conference on Neurology and Cognitive Neuroscience, October 18-19, 2018, Warsaw, Poland

Session on  Clinical Trials on Alzheimer’s disease

More than 400 clinical trials are presently looking at new treatments for Alzheimer’s disease (AD) and many of them are actively recruiting. Many of the researches are based on decreasing the toxic effects of amyloid-beta in the brain, targeting amyloid production, blocking the accumulation of amyloid-beta into plaques, Aiming at Tau, Improving Cognition with Serotonin and Dietary Supplements.

Related Topics:  Preclinical Investigation to Clinical Trials | Treatment Trials | Prevention Trials | Diagnostic Trials | Screening Trials| Quality of Life Trials | Clinical Studies of Alzheimer’s| Clinical trial design and methods | Treatments Aimed at Reducing Symptoms | Randomised Clinical Trials

4th International Conference on Central Nervous System Disorders & Therapeutics, November 12-14, 2018, Edinburgh, Scotland. World Summit on Spine and Spinal Disorders, July 27-28, 2018,  Atlanta, USA. World Summit on Alzheimer’s Disease, Dementia Care Research and Awareness, Aug 31-Sept 01, 2018, Boston, USA; 7th International Conference on Addiction Research & Therapy, Sept 19-20 2018, San Diego, USA; International Conference on Brain Disorders and Dementia Care, Sept 21-22, 2018, Philadelphia, USA; International Conference on Sleep Disorders and Medicine, Sept 21-22, 2018, Philadelphia, USA; International Conference on Neuroimmunology and Neurological Disorders, Sept 26-27, 2018, Montreal, Canada ; World Summit on Neurology & Neuroscience, Sept 26-27, 2018, Montreal, Canada ; 5th International Conference on Parkinson’s Disease & Movement Disorders, Oct 19-20, 2018, Baltimore, USA; 7th International Conference on Neurological Disorders & Stroke, September 20-21, 2018, Rome, Italy; 27th International Conference on Neurology and Cognitive Neuroscience, October 18-19, 2018, Warsaw, Poland

Session on  Vascular dementia

Vascular dementia is the wider term for dementia associated with brain damage from impaired blood flow to the brain. The various types of dementia are Single-infarct, Multi-infarct dementia, Subcortical vascular dementia (Binswanger's disease), and Mixed dementia. Its clinical symptoms are Problems with planning or organising, concentrating, including short periods of sudden confusion and Memory, language and visuospatial skills also get affected.

Anyone can be affected by Vascular dementia, but several factors increase the risk. These include: High blood pressure, Smoking, Diabetes, High cholesterol, History of mild warning strokes, Evidence of disease in arteries elsewhere and Heart rhythm abnormalities, while no remedy can reverse the damage that has already been occurred, treatment to prevent extra strokes may be very essential.

Related Topics: Dementia with Lewy bodies | Frontotemporal dementia | Amyotrophic Lateral Sclerosis | Computerised tomography | Magnetic resonance imaging | Causes and Risks factors| Treatment and outcomes | Stroke-related dementia | Post-stroke dementia | Single-infarct and multi-infarct dementia| Subcortical dementia | Progression and later stages | Hallucinations or Delusions

4th International Conference on Central Nervous System Disorders & Therapeutics, November 12-14, 2018, Edinburgh, Scotland. World Summit on Spine and Spinal Disorders, July 27-28, 2018,  Atlanta, USA. World Summit on Alzheimer’s Disease, Dementia Care Research and Awareness, Aug 31-Sept 01, 2018, Boston, USA; 7th International Conference on Addiction Research & Therapy, Sept 19-20 2018, San Diego, USA; International Conference on Brain Disorders and Dementia Care, Sept 21-22, 2018, Philadelphia, USA; International Conference on Sleep Disorders and Medicine, Sept 21-22, 2018, Philadelphia, USA; International Conference on Neuroimmunology and Neurological Disorders, Sept 26-27, 2018, Montreal, Canada ; World Summit on Neurology & Neuroscience, Sept 26-27, 2018, Montreal, Canada ; 5th International Conference on Parkinson’s Disease & Movement Disorders, Oct 19-20, 2018, Baltimore, USA; 7th International Conference on Neurological Disorders & Stroke, September 20-21, 2018, Rome, Italy; 27th International Conference on Neurology and Cognitive Neuroscience, October 18-19, 2018, Warsaw, Poland

Session on  Ageing and Gerontology

Gerontology is scientific study of aging process and concerned with physical, mental, and social aspects and implications of aging. The field of gerontology is actually quite broader, containing many professionals who focus on different aspects of aging and development.

Gerontologists include practitioners and researchers in the areas fields of nursing, medicine, criminology, biology, social work, physical and occupational therapy, psychology, sociology, psychiatry, dentistry, economics, political science, architecture, geography, pharmacy, public health, housing, and anthropology. There are several theories of aging but none has been accepted.

Related Topics: Cognitive and Functional Decline | Depression| Mobility| Nutrition | Hormonal Replacement | Frailty/Sarcopenia | Cardiovascular disease | Immune system with aging | Geriatrics Health and Caregiving | Connecting With Caregivers | Integrated Health Care | Gerontology and Geropsychologists | Behavioural and Psychological Symptoms | Aging and Mental Health | Health and Wellness | Healthcare and Aging | Aging Network| Hearing Loss|  Mitochondrial DNA mutations | Oxidative stress

4th International Conference on Central Nervous System Disorders & Therapeutics, November 12-14, 2018, Edinburgh, Scotland. World Summit on Spine and Spinal Disorders, July 27-28, 2018,  Atlanta, USA. World Summit on Alzheimer’s Disease, Dementia Care Research and Awareness, Aug 31-Sept 01, 2018, Boston, USA; 7th International Conference on Addiction Research & Therapy, Sept 19-20 2018, San Diego, USA; International Conference on Brain Disorders and Dementia Care, Sept 21-22, 2018, Philadelphia, USA; International Conference on Sleep Disorders and Medicine, Sept 21-22, 2018, Philadelphia, USA; International Conference on Neuroimmunology and Neurological Disorders, Sept 26-27, 2018, Montreal, Canada ; World Summit on Neurology & Neuroscience, Sept 26-27, 2018, Montreal, Canada ; 5th International Conference on Parkinson’s Disease & Movement Disorders, Oct 19-20, 2018, Baltimore, USA; 7th International Conference on Neurological Disorders & Stroke, September 20-21, 2018, Rome, Italy; 27th International Conference on Neurology and Cognitive Neuroscience, October 18-19, 2018, Warsaw, Poland

Session on  Geriatrics Care Practice and Awareness Neuroscience

Geriatric health care practice also known as "elder care health management, it is a process of planning and coordinating care of the old aged individuals and others with physical and/or mental abilities to meet their long term care needs, enhance their quality of life, and carried their independence for as long as possible. It involves in working with persons of old age and their families in managing, rendering and furnishing various types of health and social care services.

Awareness is attention plus working memory, and Awareness has a quite specific definition, Neural systems that controls and regulate to attenuate awareness in humans whose central and peripheral nervous system provides more instructions than cognitive sites in the brain can assimilate.

Related Topics: Geriatric emergency medicine | Geriatric neurology | Geriatric psychiatry | Gerontology | caregiver support

Support devices & monitoring4th International Conference on Central Nervous System Disorders & Therapeutics, November 12-14, 2018, Edinburgh, Scotland. World Summit on Spine and Spinal Disorders, July 27-28, 2018,  Atlanta, USA. World Summit on Alzheimer’s Disease, Dementia Care Research and Awareness, Aug 31-Sept 01, 2018, Boston, USA; 7th International Conference on Addiction Research & Therapy, Sept 19-20 2018, San Diego, USA; International Conference on Brain Disorders and Dementia Care, Sept 21-22, 2018, Philadelphia, USA; International Conference on Sleep Disorders and Medicine, Sept 21-22, 2018, Philadelphia, USA; International Conference on Neuroimmunology and Neurological Disorders, Sept 26-27, 2018, Montreal, Canada ; World Summit on Neurology & Neuroscience, Sept 26-27, 2018, Montreal, Canada ; 5th International Conference on Parkinson’s Disease & Movement Disorders, Oct 19-20, 2018, Baltimore, USA; 7th International Conference on Neurological Disorders & Stroke, September 20-21, 2018, Rome, Italy; 27th International Conference on Neurology and Cognitive Neuroscience, October 18-19, 2018, Warsaw, Poland

Session on  Cognitive Neuroscience and Artificial Intelligence

Cognitive neuroscience is scientific study of neural mechanisms which connects cognitive psychology, neurobiology, neurology, mathematics, physics, linguistics, philosophy and computer science, as well as artificial intelligence, which includes psychophysical experiments, electrophysiological studies of neural systems, functional neuroimaging, and increasingly  cognitive genomics and behavioural genetics.Artificial Intelligence (AI) entails the study of cognitive phenomena in machines one of the realistic desires of artificial intelligence is to put aspects of human intelligence in computer systems. 

Related Topics: Cognition and Intelligence | Memory Modulation | Brain Stimulation | Cognition and Decision-Making | computational analysis | Attention, Sensation, and Perception| Cognitive psychology | Cognitive behavioural therapy | Emotional and Social Processes | Language, Learning, and Memory | Collective behaviour | Artificial intelligence | computational intelligence

4th International Conference on Central Nervous System Disorders & Therapeutics, November 12-14, 2018, Edinburgh, Scotland. World Summit on Spine and Spinal Disorders, July 27-28, 2018,  Atlanta, USA. World Summit on Alzheimer’s Disease, Dementia Care Research and Awareness, Aug 31-Sept 01, 2018, Boston, USA; 7th International Conference on Addiction Research & Therapy, Sept 19-20 2018, San Diego, USA; International Conference on Brain Disorders and Dementia Care, Sept 21-22, 2018, Philadelphia, USA; International Conference on Sleep Disorders and Medicine, Sept 21-22, 2018, Philadelphia, USA; International Conference on Neuroimmunology and Neurological Disorders, Sept 26-27, 2018, Montreal, Canada ; World Summit on Neurology & Neuroscience, Sept 26-27, 2018, Montreal, Canada ; 5th International Conference on Parkinson’s Disease & Movement Disorders, Oct 19-20, 2018, Baltimore, USA; 7th International Conference on Neurological Disorders & Stroke, September 20-21, 2018, Rome, Italy; 27th International Conference on Neurology and Cognitive Neuroscience, October 18-19, 2018, Warsaw, Poland

Session on  Neurodegeneration and Genetics

Neurodegeneration marked by gradual loss of neuronal structure and its functions, including death of neurons, The most common neurodegenerative diseases are Alzheimer’s disease and Parkinson’s disease. Degenerative nerve diseases have an effect on many of your body's activities, which includes balance, movement, talking, respiration, and coronary heart function, many of these diseases are genetic, sometimes the reason is a scientific condition which include alcoholism, a tumour, or a stroke, other reasons can also include pollution, chemicals, and viruses, sometimes the purpose is not known. Degenerative nerve diseases include Alzheimer's disease, Amyotrophic lateral sclerosis, Friedreich's ataxia, Huntington's disease, Lewy body disease, Parkinson's disease and Spinal muscular atrophy.

Related Topics: Epidemiology of Neurodegenerative disease | Molecular bases of neurodegenerative disease | Disease-relevant variants in Sporadic diseases | Gene expression | Genetic epidemiology | Genetic Mutations | Neurogenetics | Neurogenesis | Glutamine and Polyglutamine | Protein misfolding | Beta amyloid | Senile plaques | Prion and transmissible spongiform encephalopathies |  Epigenetic therapy

4th International Conference on Central Nervous System Disorders & Therapeutics, November 12-14, 2018, Edinburgh, Scotland. World Summit on Spine and Spinal Disorders, July 27-28, 2018,  Atlanta, USA. World Summit on Alzheimer’s Disease, Dementia Care Research and Awareness, Aug 31-Sept 01, 2018, Boston, USA; 7th International Conference on Addiction Research & Therapy, Sept 19-20 2018, San Diego, USA; International Conference on Brain Disorders and Dementia Care, Sept 21-22, 2018, Philadelphia, USA; International Conference on Sleep Disorders and Medicine, Sept 21-22, 2018, Philadelphia, USA; International Conference on Neuroimmunology and Neurological Disorders, Sept 26-27, 2018, Montreal, Canada ; World Summit on Neurology & Neuroscience, Sept 26-27, 2018, Montreal, Canada ; 5th International Conference on Parkinson’s Disease & Movement Disorders, Oct 19-20, 2018, Baltimore, USA; 7th International Conference on Neurological Disorders & Stroke, September 20-21, 2018, Rome, Italy; 27th International Conference on Neurology and Cognitive Neuroscience, October 18-19, 2018, Warsaw, Poland

Session on  Memory Disorders

Memory Disorders is a collective term marked by damage or injury of neuroanatomical structures that affects the storage, retention and memory recall process of brain, The major causes for memory impairment are Brain strokes, High blood pressure, Medications, Diabetes, Brain trauma or head injury and nutritional deficiencies.

A various types of diseases in which memory storage get halted are Alzheimer's Disease, Corticobasal Degeneration, Creutzfeldt-Jakob Disease, Frontotemporal Dementia, Huntington's Disease, Lewy Body Dementia, Mild Cognitive Impairment, Progressive Supranuclear Palsy and Vascular Dementia.

Related Topics:  Astereognosis | Traumatic brain injury | Hyperthymestic syndrome | Wernicke- Korsakoff's syndrome | recollection of memories

4th International Conference on Central Nervous System Disorders & Therapeutics, November 12-14, 2018, Edinburgh, Scotland. World Summit on Spine and Spinal Disorders, July 27-28, 2018,  Atlanta, USA. World Summit on Alzheimer’s Disease, Dementia Care Research and Awareness, Aug 31-Sept 01, 2018, Boston, USA; 7th International Conference on Addiction Research & Therapy, Sept 19-20 2018, San Diego, USA; International Conference on Brain Disorders and Dementia Care, Sept 21-22, 2018, Philadelphia, USA; International Conference on Sleep Disorders and Medicine, Sept 21-22, 2018, Philadelphia, USA; International Conference on Neuroimmunology and Neurological Disorders, Sept 26-27, 2018, Montreal, Canada ; World Summit on Neurology & Neuroscience, Sept 26-27, 2018, Montreal, Canada ; 5th International Conference on Parkinson’s Disease & Movement Disorders, Oct 19-20, 2018, Baltimore, USA; 7th International Conference on Neurological Disorders & Stroke, September 20-21, 2018, Rome, Italy; 27th International Conference on Neurology and Cognitive Neuroscience, October 18-19, 2018, Warsaw, Poland

Session on  Neuro-immunology

Neuro-immunology is a vast branch of science that combines the nervous system and immune system together. This field assist in regulating thermogenesis, behavior, sleep, and mood which can be tormented by pro-inflammatory cytokines released by means of activated macrophages and monocytes throughout infection. Neuroinflammation and neuroimmune activation were shown to play a role in the aetiology of a variety of neurological problems which includes stroke, Parkinson's and Alzheimer's disease, multiple sclerosis,https://alzheimers.global-summit.com/ pain, and AIDS-related dementia, however  cytokines and chemokines also modulate CNS function in the absence of overt immunological, physiological, or mental challenges.

Related Topics:  AIDS-related dementia | AIDS-related dementia | mental challenges | stroke

4th International Conference on Central Nervous System Disorders & Therapeutics, November 12-14, 2018, Edinburgh, Scotland. World Summit on Spine and Spinal Disorders, July 27-28, 2018,  Atlanta, USA. World Summit on Alzheimer’s Disease, Dementia Care Research and Awareness, Aug 31-Sept 01, 2018, Boston, USA; 7th International Conference on Addiction Research & Therapy, Sept 19-20 2018, San Diego, USA; International Conference on Brain Disorders and Dementia Care, Sept 21-22, 2018, Philadelphia, USA; International Conference on Sleep Disorders and Medicine, Sept 21-22, 2018, Philadelphia, USA; International Conference on Neuroimmunology and Neurological Disorders, Sept 26-27, 2018, Montreal, Canada ; World Summit on Neurology & Neuroscience, Sept 26-27, 2018, Montreal, Canada ; 5th International Conference on Parkinson’s Disease & Movement Disorders, Oct 19-20, 2018, Baltimore, USA; 7th International Conference on Neurological Disorders & Stroke, September 20-21, 2018, Rome, Italy; 27th International Conference on Neurology and Cognitive Neuroscience, October 18-19, 2018, Warsaw, Poland

Session on  Movement disorders

Movement disorders refers to a group of nervous system characterized of movement disorders are clinical syndromes with both an excess of motion or a paucity of voluntary and involuntary actions. Individuals with a motion disorder suffer from a breakdown in the normal flow of neurological messages and this result in involuntary muscle motion. Common types of movement disorders are Ataxia, Cervical dystonia, Chorea, Dystonia, Functional movement disorder, Multiple system atrophy, Myoclonus, Progressive supranuclear palsy, Restless legs syndrome, Tardive dyskinesia, Tourette syndrome, Tremor and Wilson's disease.

Related Topics:  Cervical dystonia | Tourette syndrome | Tardive dyskinesia | Restless legs syndrome | Wilson's disease

4th International Conference on Central Nervous System Disorders & Therapeutics, November 12-14, 2018, Edinburgh, Scotland. World Summit on Spine and Spinal Disorders, July 27-28, 2018,  Atlanta, USA. World Summit on Alzheimer’s Disease, Dementia Care Research and Awareness, Aug 31-Sept 01, 2018, Boston, USA; 7th International Conference on Addiction Research & Therapy, Sept 19-20 2018, San Diego, USA; International Conference on Brain Disorders and Dementia Care, Sept 21-22, 2018, Philadelphia, USA; International Conference on Sleep Disorders and Medicine, Sept 21-22, 2018, Philadelphia, USA; International Conference on Neuroimmunology and Neurological Disorders, Sept 26-27, 2018, Montreal, Canada ; World Summit on Neurology & Neuroscience, Sept 26-27, 2018, Montreal, Canada ; 5th International Conference on Parkinson’s Disease & Movement Disorders, Oct 19-20, 2018, Baltimore, USA; 7th International Conference on Neurological Disorders & Stroke, September 20-21, 2018, Rome, Italy; 27th International Conference on Neurology and Cognitive Neuroscience, October 18-19, 2018, Warsaw, Poland

Session on  Neuroinfectious Diseases

Neuroinfectious Disease is an infection of nervous system that covers Brain and Spinal cord. The causative agents for neuroinfections  may be Bacteria, fungi, viruses, proins and occasionally protozoa or parasites, infection of brain results in inflammation like encephalitis, meningitis, Progressive multifocal leukoencephalopathy, HIV-associated neurodegeneration, Neurosarcoidosis, HTLV 1 myelopathy hereditary spastic paraparesis and Transverse myelitis.

Symptoms of bacterial or fungal central nervous system infections may include: Severe headache, Back pain, Stiff neck, Confusion, Weakness, Fever, Seizures and Paralysis whereas viral central nervous system  Symptoms Fever Irritability, Not wanting to eat, High-pitched cry, Head and neck pain and Seizures.

Related Topics: Progressive multifocal leukoencephalopathy | HTLV 1 myelopathy hereditary spastic paraparesis | meningitis | encephalitis

4th International Conference on Central Nervous System Disorders & Therapeutics, November 12-14, 2018, Edinburgh, Scotland. World Summit on Spine and Spinal Disorders, July 27-28, 2018,  Atlanta, USA. World Summit on Alzheimer’s Disease, Dementia Care Research and Awareness, Aug 31-Sept 01, 2018, Boston, USA; 7th International Conference on Addiction Research & Therapy, Sept 19-20 2018, San Diego, USA; International Conference on Brain Disorders and Dementia Care, Sept 21-22, 2018, Philadelphia, USA; International Conference on Sleep Disorders and Medicine, Sept 21-22, 2018, Philadelphia, USA; International Conference on Neuroimmunology and Neurological Disorders, Sept 26-27, 2018, Montreal, Canada ; World Summit on Neurology & Neuroscience, Sept 26-27, 2018, Montreal, Canada ; 5th International Conference on Parkinson’s Disease & Movement Disorders, Oct 19-20, 2018, Baltimore, USA; 7th International Conference on Neurological Disorders & Stroke, September 20-21, 2018, Rome, Italy; 27th International Conference on Neurology and Cognitive Neuroscience, October 18-19, 2018, Warsaw, Poland

Session on  Neurology and Neurosurgery

Neurology is a branch of science that deals with neurological disorders, diagnosis and treatment of conditions and illness of nervous system. Neurological learning is heavily based on the area of neurobiology, it involves the central and peripheral nervous systems consisting of their coverings, blood vessels, and all effector tissue, inclusive of muscle, Neurological exercise rely closely on the field of neuroscience that is the medical study of the nervous system.

The main types of illness neurosurgeons treats are: Tumours of the brain, spine and skull, trauma to the head and spinal cord degenerative spinal conditions and prolapsed discs, cerebral (brain) aneurysms and strokes, epilepsy, infections, movement disorders such as Parkinson’s disease , certain psychiatric disorders, congenital conditions such as spina bifida, conditions that affect cerebro-spinal fluid flow such as hydrocephalus, pituitary tumours and neuroendocrine disorders.

Related Topics:  Brain and Spinal cord | neurovascular surgery | spinal surgery | pediatric neurosurgery | functional and stereotactic neurosurgery | Neuro-Oncology and Interventional Neuroradiology | traumatology | Neurosurgery Procedures | Neuro-Trauma and Neurological Critical Care | Seizures and Pain

4th International Conference on Central Nervous System Disorders & Therapeutics, November 12-14, 2018, Edinburgh, Scotland. World Summit on Spine and Spinal Disorders, July 27-28, 2018,  Atlanta, USA. World Summit on Alzheimer’s Disease, Dementia Care Research and Awareness, Aug 31-Sept 01, 2018, Boston, USA; 7th International Conference on Addiction Research & Therapy, Sept 19-20 2018, San Diego, USA; International Conference on Brain Disorders and Dementia Care, Sept 21-22, 2018, Philadelphia, USA; International Conference on Sleep Disorders and Medicine, Sept 21-22, 2018, Philadelphia, USA; International Conference on Neuroimmunology and Neurological Disorders, Sept 26-27, 2018, Montreal, Canada ; World Summit on Neurology & Neuroscience, Sept 26-27, 2018, Montreal, Canada ; 5th International Conference on Parkinson’s Disease & Movement Disorders, Oct 19-20, 2018, Baltimore, USA; 7th International Conference on Neurological Disorders & Stroke, September 20-21, 2018, Rome, Italy; 27th International Conference on Neurology and Cognitive Neuroscience, October 18-19, 2018, Warsaw, Poland

Session on  Neurological diagnostic Biomarker

Biomarkers in neurology are an indicator assist in evaluating physiological, pathological or pharmacological affect to a therapeutic intervention. For example Alzheimer's disease biomarkers used to diagnose Alzheimer's disease are neurochemical indicators,

It been said that the beta-amyloid biomarker shows 80% or above specificity, in evaluating AD from dementia. It is believed that it acts as a biomarker will present a future for diagnosis of AD and eventually treatment of AD. Current biomarkers for Alzheimer’s are BACE1, Soluble Aβ precursor protein (sAPP) and Autoantibodies, apart from this neuroimaging like MRI, PET, SPECT, CT and others are used to asses Alzheimer’s, dementias and normal brain aging.

Related Topics: Alzheimer’s Disease Imaging Biomarkers | Alzheimer's Imaging Consortium | Amyloid and Tau imaging | Imaging Animal models | Imaging and Genetics | Structural Magnetic Resonance Imaging (MRI) | Brain Mapping | Structural imaging biomarkers | Mild Cognitive Impairment| Molecular and beta-amyloid imaging | Computed tomography (CT) | Diffusion tensor imaging | Functional MRI (fMRI)| Positron emission tomography | Magnetic resonance spectroscopy | Single photon emission computed tomography (SPECT) | Magnetic encephalography (MEG) | Neuroimaging techniques | Cerebrospinal Fluid Biomarker| Clinical Neuroimaging | Neurofibrillary Tangles (Nfts)| Musculoskeletal Imaging | Biomarker in Neuroimaging | Neurobiotics | Neural Tissue Engineering

4th International Conference on Central Nervous System Disorders & Therapeutics, November 12-14, 2018, Edinburgh, Scotland. World Summit on Spine and Spinal Disorders, July 27-28, 2018,  Atlanta, USA. World Summit on Alzheimer’s Disease, Dementia Care Research and Awareness, Aug 31-Sept 01, 2018, Boston, USA; 7th International Conference on Addiction Research & Therapy, Sept 19-20 2018, San Diego, USA; International Conference on Brain Disorders and Dementia Care, Sept 21-22, 2018, Philadelphia, USA; International Conference on Sleep Disorders and Medicine, Sept 21-22, 2018, Philadelphia, USA; International Conference on Neuroimmunology and Neurological Disorders, Sept 26-27, 2018, Montreal, Canada ; World Summit on Neurology & Neuroscience, Sept 26-27, 2018, Montreal, Canada ; 5th International Conference on Parkinson’s Disease & Movement Disorders, Oct 19-20, 2018, Baltimore, USA; 7th International Conference on Neurological Disorders & Stroke, September 20-21, 2018, Rome, Italy; 27th International Conference on Neurology and Cognitive Neuroscience, October 18-19, 2018, Warsaw, Poland

Session on  Neuro-Ophthalmology

Neuro ophthalmology is a branch that deals with ophthalmic conditions and diseases with neurological problems and different optic nerve disorders. It combines Ophthalmology, Neurology, an radiology together. Neuro-ophthalmology is usually non-procedural, but neuro-ophthalmologists are well expertise to perform eye muscle surgical treatment to treat adult strabismus, optic nerve fenestration for idiopathic intracranial high blood pressure, and botulinum injections for blepharospasm or hemi facial spasm.

Related Topics: Reduced visual activity |Diplopia | nystagmus | Optic neuritis  | Photophobia | Anisocoria.

4th International Conference on Central Nervous System Disorders & Therapeutics, November 12-14, 2018, Edinburgh, Scotland. World Summit on Spine and Spinal Disorders, July 27-28, 2018,  Atlanta, USA. World Summit on Alzheimer’s Disease, Dementia Care Research and Awareness, Aug 31-Sept 01, 2018, Boston, USA; 7th International Conference on Addiction Research & Therapy, Sept 19-20 2018, San Diego, USA; International Conference on Brain Disorders and Dementia Care, Sept 21-22, 2018, Philadelphia, USA; International Conference on Sleep Disorders and Medicine, Sept 21-22, 2018, Philadelphia, USA; International Conference on Neuroimmunology and Neurological Disorders, Sept 26-27, 2018, Montreal, Canada ; World Summit on Neurology & Neuroscience, Sept 26-27, 2018, Montreal, Canada ; 5th International Conference on Parkinson’s Disease & Movement Disorders, Oct 19-20, 2018, Baltimore, USA; 7th International Conference on Neurological Disorders & Stroke, September 20-21, 2018, Rome, Italy; 27th International Conference on Neurology and Cognitive Neuroscience, October 18-19, 2018, Warsaw, Poland

Session on  Nursing Interventions

Health nursing is a well experienced and qualified nurse in mental health that cares for people of all ages with mental conditions like schizophrenia, psychosis, bipolar disorder, depression, anxiety, dementia, and many more. Mental health nurses, especially CPNs, are involved in counselling, which can range from casual chats through to based, one-to-one psychotherapy sessions.

The major duty of a psychiatric nurse is to maintain a healthy and positive therapeutic relationship with patients and direct communication is necessary for developing it.

Related Topics: Disturbed Thought Process | Chronic Confusion | Impaired Verbal Communication | Nonverbal club | Memory clubs | cognitive and motor function | Self-care assistance | Psychological and pharmacological treatments | Cognitive assessment of older adults | Nursing care and practice | Nursing Education and Recovery

4th International Conference on Central Nervous System Disorders & Therapeutics, November 12-14, 2018, Edinburgh, Scotland. World Summit on Spine and Spinal Disorders, July 27-28, 2018,  Atlanta, USA. World Summit on Alzheimer’s Disease, Dementia Care Research and Awareness, Aug 31-Sept 01, 2018, Boston, USA; 7th International Conference on Addiction Research & Therapy, Sept 19-20 2018, San Diego, USA; International Conference on Brain Disorders and Dementia Care, Sept 21-22, 2018, Philadelphia, USA; International Conference on Sleep Disorders and Medicine, Sept 21-22, 2018, Philadelphia, USA; International Conference on Neuroimmunology and Neurological Disorders, Sept 26-27, 2018, Montreal, Canada ; World Summit on Neurology & Neuroscience, Sept 26-27, 2018, Montreal, Canada ; 5th International Conference on Parkinson’s Disease & Movement Disorders, Oct 19-20, 2018, Baltimore, USA; 7th International Conference on Neurological Disorders & Stroke, September 20-21, 2018, Rome, Italy; 27th International Conference on Neurology and Cognitive Neuroscience, October 18-19, 2018, Warsaw, Poland

Session on  Neuro-Oncology

Neuro-oncology deals with the study of brain and spinal cord tumours, which is usually life threatening. The most common causes of tumours are environmental toxins, genetics, stress, diet, local trauma or injury and inflammation or infection. Types include malignant tumour and benign tumours. The most common symptom is Headaches as result of intracranial pressure an early symptom of brain it get worsened by Valsalva maneuver causing awakening from sleep which is quite different than migraine. In tumours BBB get disrupted, once there is a disruption of the BBB it can be detected by MRI and CT is considered as a main indicator for diagnosis of tumours like meningioma’s, malignant gliomas and brain metastases.

Related Topics: Meningioma’s | Brain metastases | Valsalva maneuver | pontine glioma | spinal cord neoplasms | Tumor markers

4th International Conference on Central Nervous System Disorders & Therapeutics, November 12-14, 2018, Edinburgh, Scotland. World Summit on Spine and Spinal Disorders, July 27-28, 2018,  Atlanta, USA. World Summit on Alzheimer’s Disease, Dementia Care Research and Awareness, Aug 31-Sept 01, 2018, Boston, USA; 7th International Conference on Addiction Research & Therapy, Sept 19-20 2018, San Diego, USA; International Conference on Brain Disorders and Dementia Care, Sept 21-22, 2018, Philadelphia, USA; International Conference on Sleep Disorders and Medicine, Sept 21-22, 2018, Philadelphia, USA; International Conference on Neuroimmunology and Neurological Disorders, Sept 26-27, 2018, Montreal, Canada ; World Summit on Neurology & Neuroscience, Sept 26-27, 2018, Montreal, Canada ; 5th International Conference on Parkinson’s Disease & Movement Disorders, Oct 19-20, 2018, Baltimore, USA; 7th International Conference on Neurological Disorders & Stroke, September 20-21, 2018, Rome, Italy; 27th International Conference on Neurology and Cognitive Neuroscience, October 18-19, 2018, Warsaw, Poland

Session on  Dementia Care Practice and Research

Dementia is a chronic condition of the mental health caused by brain disease or injury marked by memory inabilities, personality impairments, and impaired reasoning. Dementia care practice is a process optimizing patient’s quality of life, functional independence, health, and wellbeing, all of whom may additionally struggle physically, emotionally, and financially from their diverse relationships to the sickness.

Related Topics: Assessment and care planning | Behavioural interventions| Public Health and Psychosocial Factors/Epidemiology | Cross-cultural studies and cultural/linguistic adaptations| Community care and Family/lay caregiving | Therapeutic strategies and interventions | Psychosocial Research in Dementia | Technology Research-Mobile technology | Home-based technology and Social Networking | Technology, innovation and entrepreneurship | Applied research in dementia | Biomarker research, early detection and precision| Person centered care | Cognitive training | Atherosclerosis of Dementia| Apolipoprotein E Dementia|

4th International Conference on Central Nervous System Disorders & Therapeutics, November 12-14, 2018, Edinburgh, Scotland. World Summit on Spine and Spinal Disorders, July 27-28, 2018,  Atlanta, USA. World Summit on Alzheimer’s Disease, Dementia Care Research and Awareness, Aug 31-Sept 01, 2018, Boston, USA; 7th International Conference on Addiction Research & Therapy, Sept 19-20 2018, San Diego, USA; International Conference on Brain Disorders and Dementia Care, Sept 21-22, 2018, Philadelphia, USA; International Conference on Sleep Disorders and Medicine, Sept 21-22, 2018, Philadelphia, USA; International Conference on Neuroimmunology and Neurological Disorders, Sept 26-27, 2018, Montreal, Canada ; World Summit on Neurology & Neuroscience, Sept 26-27, 2018, Montreal, Canada ; 5th International Conference on Parkinson’s Disease & Movement Disorders, Oct 19-20, 2018, Baltimore, USA; 7th International Conference on Neurological Disorders & Stroke, September 20-21, 2018, Rome, Italy; 27th International Conference on Neurology and Cognitive Neuroscience, October 18-19, 2018, Warsaw, Poland

Session on   Neurology Palliative Care

The importance of palliative care extends far past ‘end-of-lifestyles treatment for most cancers sufferers, There are some of crucial regions for palliative care exactly in neurology and a regularly developing call for it – now not least because of ever higher lifestyles expectancy charges worldwide.

Example of patients with glioblastoma with this progressive disorder, the need for palliative care constantly will increase. It’s far tough to mention for sure the factor in time at which palliative care need so be initiated, experience shows that factors of palliative medicinal drug are employed and primarily, organized early on in the path of the disorder, even at some point of oncological treatment.

Related Topics Supportive care | care provider responsibilities | Emerging Subspecialties in Neurology care

4th International Conference on Central Nervous System Disorders & Therapeutics, November 12-14, 2018, Edinburgh, Scotland. World Summit on Spine and Spinal Disorders, July 27-28, 2018,  Atlanta, USA. World Summit on Alzheimer’s Disease, Dementia Care Research and Awareness, Aug 31-Sept 01, 2018, Boston, USA; 7th International Conference on Addiction Research & Therapy, Sept 19-20 2018, San Diego, USA; International Conference on Brain Disorders and Dementia Care, Sept 21-22, 2018, Philadelphia, USA; International Conference on Sleep Disorders and Medicine, Sept 21-22, 2018, Philadelphia, USA; International Conference on Neuroimmunology and Neurological Disorders, Sept 26-27, 2018, Montreal, Canada ; World Summit on Neurology & Neuroscience, Sept 26-27, 2018, Montreal, Canada ; 5th International Conference on Parkinson’s Disease & Movement Disorders, Oct 19-20, 2018, Baltimore, USA; 7th International Conference on Neurological Disorders & Stroke, September 20-21, 2018, Rome, Italy; 27th International Conference on Neurology and Cognitive Neuroscience, October 18-19, 2018, Warsaw, Poland

Session on  Neuro stroke

A stroke or cerebrovascular accident is the unexpectedly growing loss of brain functions because of disturbance in the blood supply to the brain, caused by a blocked or burst blood vessel. In emergency conditions neurological damage get worsened which may results in bleeding (haemorrhagic strokes) and death. The strokes like ischemic stroke, thrombotic stroke, haemorrhagic stroke, intracerebral haemorrhage and subarachnoid haemorrhage are the various types of neuro strokes.

Symptoms includes sudden onset of numbness, weakness, confusion, difficulty speaking, vision loss, dizziness, imbalance and severe headache. It can be prevented by monitoring diet, regulating blood pressure and diabetes levels, physical work out and quitting smoking.

Related Topics: haemorrhagic stroke | neuro injury | neurological damage | subarachnoid haemorrhage

4th International Conference on Central Nervous System Disorders & Therapeutics, November 12-14, 2018, Edinburgh, Scotland. World Summit on Spine and Spinal Disorders, July 27-28, 2018,  Atlanta, USA. World Summit on Alzheimer’s Disease, Dementia Care Research and Awareness, Aug 31-Sept 01, 2018, Boston, USA; 7th International Conference on Addiction Research & Therapy, Sept 19-20 2018, San Diego, USA; International Conference on Brain Disorders and Dementia Care, Sept 21-22, 2018, Philadelphia, USA; International Conference on Sleep Disorders and Medicine, Sept 21-22, 2018, Philadelphia, USA; International Conference on Neuroimmunology and Neurological Disorders, Sept 26-27, 2018, Montreal, Canada ; World Summit on Neurology & Neuroscience, Sept 26-27, 2018, Montreal, Canada ; 5th International Conference on Parkinson’s Disease & Movement Disorders, Oct 19-20, 2018, Baltimore, USA; 7th International Conference on Neurological Disorders & Stroke, September 20-21, 2018, Rome, Italy; 27th International Conference on Neurology and Cognitive Neuroscience, October 18-19, 2018, Warsaw, Poland

Session on  Mood disorders

Mood disorders are a set of illnesses that presents a serious change in mood. The major categories are Depression and Bipolar disorders. The subject may experience euphoric, mania, hyperactive, over inflated ego, persistent depressive disorder and seasonal depressive disorders. The Psychiatric Disorders and Mood Disorders is interlinked in its nature it means that the subject with psychiatric disorders has a chance of developing Depression. The other mood disorders are Cyclothymic disorder, premenstrual dysphoric disorder, Persistent depressive disorder (dysthymia), Disruptive mood dysregulation disorder and Depression induced by substance use or medication.

Related Topics:  mania or hypomania | major depressive disorder | bipolar disorder | cyclothymic disorder

4th International Conference on Central Nervous System Disorders & Therapeutics, November 12-14, 2018, Edinburgh, Scotland. World Summit on Spine and Spinal Disorders, July 27-28, 2018,  Atlanta, USA. World Summit on Alzheimer’s Disease, Dementia Care Research and Awareness, Aug 31-Sept 01, 2018, Boston, USA; 7th International Conference on Addiction Research & Therapy, Sept 19-20 2018, San Diego, USA; International Conference on Brain Disorders and Dementia Care, Sept 21-22, 2018, Philadelphia, USA; International Conference on Sleep Disorders and Medicine, Sept 21-22, 2018, Philadelphia, USA; International Conference on Neuroimmunology and Neurological Disorders, Sept 26-27, 2018, Montreal, Canada ; World Summit on Neurology & Neuroscience, Sept 26-27, 2018, Montreal, Canada ; 5th International Conference on Parkinson’s Disease & Movement Disorders, Oct 19-20, 2018, Baltimore, USA; 7th International Conference on Neurological Disorders & Stroke, September 20-21, 2018, Rome, Italy; 27th International Conference on Neurology and Cognitive Neuroscience, October 18-19, 2018, Warsaw, Poland

Session on  Neuropharmacology and Neurobiochemistry

Neuropharmacology is the study of drug actions on nervous system, mainly deals in developing the compounds for human’s benefits with psychiatric and neurological disease. Behavioural neuropharmacology focuses on how drugs have an effect on human behavior (neuropsychopharmacology), along with the study of how drug dependence and addiction affect the human brain. In depth it represents the neural mechanism and interactions of neurotransmitters, neuromodulators, enzymes, second messengers, neuropeptides, necrohormones, co-transporters, ion channels, and receptor proteins in the central and peripheral nervous systems. Neurochemistry is the study of neurochemicals which consist of neuromessenger and other molecules such as psychopharmaceuticals and neuropeptides, that effect the function of neurons by operating of neurons, synapses and neural networks. Neurochemists examine biochemistry and molecular biology of organic compounds in the brain and their functions in neural processes as brain plasticity, neurogenesis, and neural differentiation.

Related Topics:  Neurogenesis and Gliogenesis | Postnatal Neurogenesis | Stem Cells | Axon and Dendrite Development | Synaptogenesis | Developmental Cell Death | Transplantation and Regeneration | Neurotransmitters and Signaling Molecules | Ligand Gated Ion Channels  | G-Protein Linked Receptors | Glia-Neuron Interactions | Electrophysiology | Neurobiology | Clinical Neurophysiology | Neuroanatomy | Neural coding

4th International Conference on Central Nervous System Disorders & Therapeutics, November 12-14, 2018, Edinburgh, Scotland. World Summit on Spine and Spinal Disorders, July 27-28, 2018,  Atlanta, USA. World Summit on Alzheimer’s Disease, Dementia Care Research and Awareness, Aug 31-Sept 01, 2018, Boston, USA; 7th International Conference on Addiction Research & Therapy, Sept 19-20 2018, San Diego, USA; International Conference on Brain Disorders and Dementia Care, Sept 21-22, 2018, Philadelphia, USA; International Conference on Sleep Disorders and Medicine, Sept 21-22, 2018, Philadelphia, USA; International Conference on Neuroimmunology and Neurological Disorders, Sept 26-27, 2018, Montreal, Canada ; World Summit on Neurology & Neuroscience, Sept 26-27, 2018, Montreal, Canada ; 5th International Conference on Parkinson’s Disease & Movement Disorders, Oct 19-20, 2018, Baltimore, USA; 7th International Conference on Neurological Disorders & Stroke, September 20-21, 2018, Rome, Italy; 27th International Conference on Neurology and Cognitive Neuroscience, October 18-19, 2018, Warsaw, Poland

https://en.wikipedia.org/wiki/Neurochemistry

https://en.wikipedia.org/wiki/Neuropharmacology

https://www.dementia.org.au/about-dementia/types-of-dementia/vascular-dementia      

https://www.alz.org/alzheimers_disease_what_is_alzheimers.asp

Market Analysis:

Alzheimer's disease is a 6th leading cause of death in USA, The key driving component for the improvement of the worldwide Alzheimer's medication advertise is the expanding predominance of the sickness in the created.The worldwide Alzheimer's medications advertise remained at a general valuation of US$3.6 bn in the years 2017. This valuation is evaluated to reach to a figure of US$6.4 bn before the finish of the given conjecture time of 2017 to 2025. This development in the general market valuation is relied upon to be accomplished at an unfaltering development CAGR of 7.5% through the span of the given gauge time frame.

Data monitor Healthcare assesses that in 2014, there were 9.5 million predominant instances of Alzheimer's illnesses in the U.S.A, Japan, and five noteworthy EU markets Datamonitor Healthcare anticipates that these nations will demonstrate positive development in the quantity of prevelant instances of Alzheimer's infection over the estimate time frame (2014-34).

Participation Benefits

  • Access to all Scientific Sessions.
  • Will be felicitated with International Organising Committee Member (IOCM) Certificate.
  • Remarkable Awards and Global Recognition to meritorious Researchers.
  • Nominations for Best Poster Award.
  • Outstanding Young Researcher Award geared towards best budding young research.
  • Group Registration benefits.
  • Collaborations across Academia & Industry.
  • Platform to Global investment community to connect with stakeholders  and sponsorships.

 

Past Conference Report

9th International Conference on Alzheimer’s Disease & Dementia

Dementia 2017 Report

9th International Conference on Alzheimer’s Disease & Dementia was organized during October 16-18, 2017 at Holiday Inn Aurelia, Rome, Italy with the support and contribution of the Organizing Committee Members.

Firstly we must thank you for trusting us and participating at Dementia 2017, a global platform to discuss various important aspects of Alzheimer’s disease, Dementia and Neurological disorders.

There are infinite reasons to extend our gratitude to you for making Dementia 2017 an outstanding conference. We couldn’t have done it without your continuous support and believe towards our organization, which mutually made to achieve Dementia 2017 a new heights in the field of Neuroscience.

The conference was marked with the attendance of young and brilliant researchers, business delegates, Exhibitors and talented student communities representing more than 15 countries, who have driven this event into the path of success.

The conference was organized around the theme “An Insight into Advanced Research and Diagnostic Approaches in Alzheimer’s Disease and Dementia”. The event implanted a firm relation of upcoming strategies in the field of Research and Developments in Dementia with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

The conference proceedings were carried out through various Scientific-sessions and plenary lectures.

The conference witnessed an amalgamation of peerless speakers, Keynote sessions, workshops, symposium well-known researchers and delegates who enlightened the crowd with their enviable research knowledge and on various alluring topics related to the field of Neurology, Alzheimer’s disease and Dementia through their fabulous presentations at the podium of Dementia 2017.

For 2018 we are expanding our focus towards all aspects of Alzheimer’s Disease & Dementia Research findings. Our organizing committee is gearing up with more innovative and explorative sessions to unleash the boundaries of the Neurology Neurological disorders, Alzheimer’s Disease & Dementia.

All accepted abstracts have been indexed in the supporting Journals as a special issue. Conference Series felicitated all the Organizing Committee Members who enthusiastically participated in the conference and made this meeting a huge success.

5th International Conference on Alzheimer’s Disease & Dementia

Dementia 2016 Report

5th International Conference on Alzheimer’s Disease & Dementia was organized during September 29-October 01, 2016 at Hilton London Heathrow Airport, London, UK with the support and contribution of the Organizing Committee Members.

All the participants were awarded with 5.25 AMA PRA Category 1 CreditsTM

Firstly we must thank you for trusting us and participating at Dementia 2016, a global platform to discuss various important aspects of Alzheimer’s disease, Dementia and Neurological disorders.

There are infinite reasons to extend our gratitude to you for making Dementia 2016 an outstanding conference. We couldn’t have done it without your continuous support and believe towards our organization, which mutually made to achieve Dementia 2016 a new heights in the field of Neuroscience.

The conference was marked with the attendance of young and brilliant researchers, business delegates, Exhibitors and talented student communities representing more than 15 countries, who have driven this event into the path of success.

The conference was organized around the theme “An Insight into Advanced Research and Diagnostic Approaches in Alzheimer’s Disease and Dementia”. The event implanted a firm relation of upcoming strategies in the field of Research and Developments in Dementia with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

The conference proceedings were carried out through various Scientific-sessions and plenary lectures, of which the following Speakers were highlighted as

Keynote speakers:

Claude M Wischik, TauRx Therapeutics, UK

Jerzy Leszek, Wroclaw Medical University, Poland

Jordan L Holtzman, University of Minnesota, USA

Linda Levine Madori, St Thomas Aquinas College, USA

Zhicheng Xiao, Monash University, Australia

Xiaoliang Wang, Chinese Academy of Medical Sciences, China

Workshops:

Wake up London – Raising awareness of dementia in London’s Black, Asian and Minority ethnic communities presented by David Truswell, Central and North West London NHS Foundation Trust, UK, Luis Angel Francisco Sorroza Lopez, University La Salle Mexico, Mexico and Laura Templeton, University College London, UK.

The conference witnessed an amalgamation of peerless speakers, Keynote sessions, workshops, symposium well-known researchers and delegates who enlightened the crowd with their enviable research knowledge and on various alluring topics related to the field of Neurology, Alzheimer’s disease and Dementia through their fabulous presentations at the podium of Dementia 2016. So as a continuation of Dementia 2016, we would like to heartily invite you to our upcoming 8th International Conference on Alzheimer’s Disease & Dementia during October 16-18, 2017 at Rome, Italy.

For 2017 we are expanding our focus towards all aspects of Alzheimer’s Disease & Dementia Research findings. Our organizing committee is gearing up with more innovative and explorative sessions to unleash the boundaries of the Neurology Neurological disorders, Alzheimer’s Disease & Dementia.

All accepted abstracts have been indexed in the supporting Journals as a special issue. Conference Series felicitated all the Organizing Committee Members who enthusiastically participated in the conference and made this meeting a huge success.

We would like to proudly announce “8th International Conference on Alzheimer’s Disease & Dementia” during October 16-18, 2017 in Rome, Italy.

We wish to pioneer a way to another outstanding event in the Italy.

Important Dates

Final call for registration: August 31st. 

Avail group participation discounts on more than 5 participants

Time duration for each category:

Keynote Speech: 40-45 minutes

Oral/ Plenary Speech: 30-35 minutes

Workshop: 60 minutes

 

To Collaborate Scientific Professionals around the World

Conference Date August 31-September 01, 2018

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Past Conference Report

Supported By

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by